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A novel role for shuttling SR proteins
in mRNA translation
Jeremy R. Sanford, Nicola K. Gray, Karsten Beckmann,1 and Javier F. Cáceres2
Medical Research Council Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, Scotland,
United Kingdom
The Ser–Arg-rich (SR) proteins comprise a large family of nuclear phosphoproteins that are required for
constitutive and alternative splicing. A subset of SR proteins shuttles continuously between the nucleus and
the cytoplasm, suggesting that the role of shuttling SR proteins in gene expression may not be limited to
nuclear pre-mRNA splicing, but may also include unknown cytoplasmic functions. Here, we show that
shuttling SR proteins, in particular SF2/ASF, associate with translating ribosomes and stimulate translation
when tethered to a reporter mRNA in Xenopus oocytes. Moreover, SF2/ASF enhances translation of reporter
mRNAs in HeLa cells, and this activity is dependent on its ability to shuttle from the nucleus to the
cytoplasm and is increased by the presence of an exonic-splicing enhancer. Furthermore, SF2/ASF can
stimulate translation in vitro using a HeLa cell-free translation system. Thus, the association of SR proteins
with translating ribosomes, as well as the stimulation of translation both in vivo and in vitro, strongly suggest
a role for shuttling SR proteins in translation. We propose that shuttling SR proteins play multiple roles in the
posttranscriptional expression of eukaryotic genes and illustrate how they may couple splicing and translation.
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Pre-mRNA splicing, an essential step in gene expression,
is catalyzed by a large ribonucleoprotein complex,
termed the spliceosome. This macromolecular machine
consists of small nuclear ribonucleoproteins particles
(snRNPs) U1, U2, U4, U5, and U6 and a multitude of
non-snRNP splicing factors that includes Ser–Arg-rich
(SR) proteins (for review, see Kramer 1996; Will and
Luhrmann 1997; Jurica and Moore 2003). The SR pro-
teins constitute a family of structurally and functionally
related proteins, playing dual roles in both constitutive
and alternative pre-mRNA splicing (Fu 1995; Valcarcel
and Green 1996; Graveley 2000). SR proteins are charac-
terized by their modular domain structure, with one or
two N-terminal RNA recognition motifs (RRMs) and a
C-terminal domain rich in arginine and serine residues,
termed the RS domain. The RRMs determine RNA-bind-
ing specificity, whereas the RS domain acts as a splicing
activator domain by mediating protein–protein interac-
tions with other components of the splicing machinery
(Wu and Maniatis 1993; Graveley and Maniatis 1998).
The RS domain also directs subcellular localization and
nucleocytoplasmic shuttling of individual SR proteins
(Hedley et al. 1995; Caceres et al. 1997, 1998).
SR proteins play numerous roles in pre-mRNA splic-
ing and spliceosome assembly, but perhaps their most
significant function is in splice-site recognition and se-
lection (Tacke and Manley 1999; Sanford et al. 2003).
Metazoan splice sites contain low information content
and are far more degenerate than those found in simpler
eukaryotes (Burge et al. 1998); thus, splice-site specific-
ity is conferred by the presence of additional sequences
that facilitate splice-site selection, such as exonic-splic-
ing enhancers and silencers (ESEs and ESSs, respec-
tively). These elements recruit trans-acting factors that
function as adapters between the pre-mRNA and the
basal-splicing machinery. For instance, SR family pro-
teins bound to ESEs can promote U2AF recruitment to
the polypyrimidine tract and activate an adjacent 3
splice site. In certain cases, SR proteins may act to an-
tagonize the negative activity of hnRNP proteins recog-
nizing ESS elements (for review, see Blencowe 2000;
Hastings and Krainer 2001; Caceres and Kornblihtt
2002). The SR proteins are not only required for consti-
tutive splicing, but also influence regulation of alterna-
tive splicing, and this activity is antagonized by hnRNP
A/B proteins in a concentration-dependent manner
(Mayeda and Krainer 1992; Caceres et al. 1994; Yang et
al. 1994). SF2/ASF and hnRNP A1 competitive binding
1Present address: European Molecular Biology Laboratory, Heidelberg
D-69117, Germany.
2Corresponding author.
E-MAIL Javier.Caceres@hgu.mrc.ac.uk; FAX 44-131-467-8456.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/
gad.286404.
GENES & DEVELOPMENT 18:755–768 © 2004 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/04; www.genesdev.org 755
to pre-mRNA underlies their functional antagonism in
splice-site selection (for review, see Hastings and Krainer
2001).
Initially, SR proteins were found to be functionally
redundant in constitutive splicing assays; however, dif-
ferences in alternative splicing regulation, as well as ge-
netic analysis of SR protein function suggested that not
all SR proteins are functionally redundant. For example,
SF2/ASF is essential for cell viability in the DT40
chicken cell line, and its depletion cannot be rescued by
overexpression of other SR proteins (Wang et al. 1996,
1998). Genetic disruption of SRp55/B52 in Drosophila
results in lethality during development, and individual
SR proteins were able to complement the loss of B52 in
most tissues, except in the brain, where B52 is the pre-
dominant protein (Ring and Lis 1994; Peng and Mount
1995; Hoffman and Lis 2000). In the mouse, SRp20 was
shown to be essential for early development (Jumaa et al.
1999), whereas conditional deletion of the SR protein
SC35 in the thymus causes a defect in T-cell maturation
(Wang et al. 2001). RNA interference (RNAi) experi-
ments with Caenorhabditis elegans SR proteins showed
that, whereas CeSF2/ASF is an essential gene, functional
knockouts of other SR genes resulted in no obvious phe-
notype, which is indicative of functional redundancy
(Kawano et al. 2000; Longman et al. 2000). These results
suggest that at least some SR proteins are functionally
redundant, and that the requirement for a particular SR
protein may be due to specific functions in the tissue or
developmental stage in which a particular SR protein is
predominant.
At steady state, SR proteins are localized in the
nucleus and are distributed both in the nucleoplasm and
in interchromatin granule clusters (IGCs) or speckles
(Spector et al. 1991; for review, see Lamond and Spector
2003). However, a subset of SR proteins shuttle continu-
ously between the nucleus and the cytoplasm, reminis-
cent of what was observed for several hnRNP proteins
(Pinol-Roma and Dreyfuss 1992; Caceres et al. 1998).
The shuttling behavior of this subset of SR proteins ar-
gues against their function being limited to the nucleus,
and allows for the possibility that shuttling SR proteins
may have additional roles in mRNA transport and/or in
cytoplasmic events such as mRNA localization, stabil-
ity, or regulation of translation. Despite the extensive
characterization of the activities of SR proteins in
nuclear pre-mRNA splicing, little is known regarding
any potential cytoplasmic functions of shuttling SR pro-
teins. In contrast, cytoplasmic activities for a number of
shuttling hnRNP proteins have been characterized and
include the roles for hnRNP A2/B1 and squid/hrp40 in
mRNA localization (Hoek et al. 1998; Lall et al. 1999)
and for hnRNP D in regulation of mRNA stability (Loflin
et al. 1999; Xu et al. 2001; for review, see Shyu and
Wilkinson 2000; Dreyfuss et al. 2002). In addition, poly-
pyrimidine tract-binding protein (hnRNP I/PTB) is es-
sential for internal initiation of translation of viral RNAs
(Kaminski et al. 1995), whereas hnRNP K and E1 medi-
ate translational silencing (Ostareck et al. 1997; Habel-
hah et al. 2001). Interestingly, two shuttling SR proteins,
SRp20 and 9G8, function to promote mRNA export of
intronless RNAs (Huang and Steitz 2001) and also act as
adapter proteins for TAP-dependent mRNA export
(Huang et al. 2003). Moreover, SF2/ASF has been shown
to control mRNA stability in the cytoplasm for a specific
mRNA (Lemaire et al. 2002).
Here, we have used a variety of assays to elucidate
putative cytoplasmic functions for shuttling SR proteins.
We show by sucrose gradient centrifugation of HeLa cy-
toplasmic extracts that two shuttling SR proteins, SF2/
ASF and SRp20, cosediment with the 80S ribosome par-
ticle, and in the case of SF2/ASF, also with polysomes. A
functional role for shuttling SR proteins in translation is
confirmed by three lines of evidence. First, we show that
SR proteins are able to stimulate translation when teth-
ered to a luciferase reporter in Xenopus oocytes. Second,
SF2/ASF is also able to stimulate translation of a reporter
in HeLa cells in an enhancer-dependent manner. Finally,
SF2/ASF can stimulate translation in vitro in a HeLa
cell-free translation system. These findings establish a
novel cytoplasmic role for shuttling SR proteins and
demonstrate that SR proteins are important determi-
nants of the fate of an mRNA from the early nuclear
RNA processing events until its translation in the cyto-
plasm.
Results
Shuttling SR proteins cosediment
with ribosomal particles
As an initial approach toward elucidating the cytoplas-
mic functions of shuttling SR proteins, HeLa cell cyto-
plasm was fractionated across 10%–50% sucrose gradi-
ents, and the distribution of SR proteins was analyzed by
Western blotting. Two shuttling SR proteins, SF2/ASF
and SRp20, were broadly distributed between the mRNP
complexes and the ribosomal subunits. Interestingly,
SF2/ASF, and to a lesser extent, SRp20, also cosedi-
mented with the 80S ribosome, as was the case for the
ribosomal protein S6, an integral component of the small
ribosomal subunit (rpS6; Fig. 1A). In contrast, the non-
shuttling SR protein, SRp40, was present only in trace
amounts in HeLa cytosolic extract and was never ob-
served cosedimenting with ribosomal complexes (data
not shown). Interestingly, a fraction of SF2/ASF was also
detected in the lighter polysomal fractions, whereas
SRp20 was absent from polysomes. Treatment of cyto-
plasmic extracts with EDTA induces dissociation of
mono- and polyribosomes into ribosomal subunits, and
under these conditions, SF2/ASF is redistributed to the
top of the gradient (Supplementary Fig. S1). Analysis of
pelleted polysomes showed that SF2/ASF and Poly(A)-
binding protein (PABP), a bona fide translational regula-
tor, cosedimented with polyribosomes as marked by the
presence of rpS6, a ribosomal subunit protein; however,
little, if any, SRp20 appeared to associate with poly-
somes (Fig. 1B). Extracts treated with EDTA, which com-
promises the integrity of ribosomes, failed to sediment
rpS6, PABP, or SF2/ASF (Fig. 1B). Thus, we conclude that
Sanford et al.
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SF2/ASF, but not SRp20, is associated with polysomes.
Taken together, these results suggest that shuttling SR
proteins can interact with the translation machinery and
may play a role in translational regulation.
Tethered SR proteins activate translation of a reporter
in Xenopus oocytes
Cosedimentation of SF2/ASF with the translation ma-
chinery suggests that SF2/ASF, and possibly other shut-
tling SR proteins, may play a role in translational regu-
lation. This hypothesis was directly tested using a vari-
ety of functional assays. First, the well-established
tethered function assay in Xenopus oocytes was used
(Gray et al. 2000). Briefly, mRNAs encoding fusion pro-
teins between the bacteriophage RNA-binding protein
MS2 and shuttling SR proteins, or bona fide translational
regulators such as PABP, were injected into Xenopus oo-
cytes. Following a 6-h incubation to allow time for pro-
tein production, oocytes were subsequently coinjected
with a luciferase reporter mRNA containing cognate
MS2-binding sites in the 3UTR (or lacking MS2 sites as
a control). A -galactosidase mRNA lacking MS2-bind-
ing sites was coinjected to control for nonspecific effects
of the MS2 fusion proteins on translation of the lucifer-
ase reporter. Translational activity was quantified as lu-
ciferase activity normalized to -galactosidase activity
as previously described (Gray et al. 2000). Figure 2A
shows that like MS2 alone, the fusion of MS2 to the U1
snRNP-specific protein U1A (MS2–U1A) was unable to
activate translation. This was not due to lack of MS2–
U1A fusion protein, as the expression of the protein can
be seen in 35S-labeled oocytes (Supplementary Fig. S2). In
contrast, PABP strongly activates translation of the re-
porter mRNA. Interestingly, MS2–SF2/ASF also acti-
vated translation when tethered to the luciferase mRNA
reporter. Synthesis of the MS2 fusion proteins was con-
firmed by 35S-met labeling of the injected oocytes
(Supplementary Fig. S2). Once corrected for the number
of methionines, translation of the MS2–SF2 fusion pro-
tein seems to be reduced compared with that of U1A or
PABP; thus, the activity of SF2/ASF could be higher than
apparent from the luciferase assays. Therefore, a shut-
tling SR protein can enhance the translation of reporter
mRNA in a heterologous in vivo translation assay (Fig.
2A). It should be noted that in this experimental system,
mRNA export becomes irrelevant, as the reporter
mRNAs (both luciferase and -galactosidase) are coin-
jected in the cytoplasm. Importantly, stimulation of
luciferase expression mediated by MS2–SF2/ASF was ob-
served in the absence of an increase in the stability of
reporter mRNA, as measured by Northern blots, indicat-
ing that the fusion proteins function at the level of trans-
lation (Fig. 2B). Furthermore, the effect of MS2–SF2/ASF
on luciferase translation was specific and occurred only
in cis, as no stimulation was observed in the absence of
MS2-binding sites in the 3UTR of the luciferase reporter
(Fig. 2C).
Next, we asked whether the RNA-binding activity of
SF2/ASF was required for its function as a translational
regulator in the tethering system. Interestingly, we
found that an RNA-binding-deficient mutant of SF2/ASF
harboring a double point mutation in its first RRM
that severely affects sequence-specific RNA binding
(Caceres and Krainer 1993) was able to stimulate trans-
lation when fused to the MS2 protein (MS2 FF-DD,
Fig. 2D). This experiment demonstrates that RNA bind-
ing is most likely required to recruit SF2/ASF to the
mRNA, rather than to promote an interaction with ribo-
somal RNAs (Fig. 2D). The RS domain of SR proteins
has been shown to function as a splicing-activator do-
main, presumably by promoting protein–protein inter-
actions with essential components of the splicing ma-
chinery (Wu and Maniatis 1993; Zuo and Maniatis 1996;
Graveley and Maniatis 1998). Therefore, we asked
whether the RS domains of both shuttling and non-
shuttling SR proteins (SF2/ASF and SC35, respectively)
could function as translational activators in vivo when
Figure 1. Shuttling SR proteins are associated with the trans-
lation machinery. (A) HeLa cell cytosolic extracts were fraction-
ated across a 10%–50% sucrose gradients and analyzed by West-
ern blotting with antibodies against SF2/ASF, SRp20, poly(A)-
binding protein (PABP), and the ribosomal protein, rpS6. (Top)
UV absorbance (254 nm) profile of cytosolic ribonucleoprotein
complexes. (B) Association of SF2/ASF with polyribosomes re-
quires intact ribosomal particles. Western blot analysis of RNA-
binding proteins associated with polyribosomes, purified by pel-
leting through a 10%–50% sucrose gradient from mock treated
(−) or EDTA-treated (+) HeLa cytosolic extracts. Unfractionated
cytosolic extract is shown in lanes designated by C.
SR proteins in translational regulation
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fused to the MS2 protein. Figure 2D shows that the RS
domain of either SR protein was sufficient to stimu-
late translation in vivo. It should be noted that the
shuttling activity of SR proteins becomes irrelevant in
this assay, as the mRNAs coding for the particular
SR fusion protein were injected in the cytoplasm. Fu-
sion proteins between MS2 and full-length SF2/ASF and
SC35 (shuttling and nonshuttling SR proteins, re-
spectively) stimulated translation to similar extents in
Xenopus oocytes (data not shown). Thus, these results
suggest that shuttling SR proteins are capable of func-
tionally interacting with the translation machinery in
vivo and that the RS domain is sufficient to mediate this
effect.
SF2/ASF activates translation of a reporter in HeLa
cells in an enhancer-dependent manner
Next, we investigated the role of the shuttling SR pro-
tein SF2/ASF in translation in mammalian cells. We de-
veloped a luciferase-based reporter system that encodes
the C-terminal 33 amino acids from -alactosidase fused
in-frame to a Firefly luciferase gene via a short synthetic
linker sequence. Restriction enzyme sites within this
linker sequence were used to insert an exonic-splicing
enhancer (ESE), derived from the EDA alternative exon
of the fibronectin gene (Caputi et al. 1994), which is
known to recruit SF2/ASF as well as 9G8 (Lavigueur et
al. 1993; Cramer et al. 1999). This ESE sequence was
Figure 2. Tethered SR proteins stimulate translation in Xenopus oocytes. (A) mRNAs encoding either the MS2 protein alone, or
fusions between MS2–U1A, MS2–SF2/ASF, and MS2–PABP were coinjected into the cytoplasm of Xenopus oocyctes with a luciferase
reporter mRNA containing MS2p-binding sites within its 3UTR and a -galactosidase mRNA lacking MS2-binding sites. The injected
fusion proteins did not significantly affect -galactosidase levels and nonspecific effects of the fusion proteins on translation were
taken into account by normalizing luciferase activity to -galactosidase activity. These data represent the average stimulation from
three independent experiments. (B) Northern blot analysis showing constant levels of mRNA reporter upon injection of MS2–U1A
(lanes 1,2) and MS2–SF2/ASF (lanes 3,4). (t) Time after injection (0 and 16 h, respectively). (C) The effect of the MS2–SF2/ASF fusion
protein is specific to reporter mRNAs containing cognate MS2-binding sites. Microinjection experiments were performed using a
luciferase reporter mRNA containing (white bars) or lacking (black bars) functional MS2-binding sites. (D) The RS domain of SR
proteins is sufficient to stimulate translation in vivo. mRNAs encoding MS2, MS2–U1A, MS2–SF2/ASF, MS2–SF2 FF–DD, MS2–RS
SF2/ASF, or MS2–RS SC35 were injected into the cytoplasm of Xenopus oocytes along with reporter mRNAs as described above. These
data represents the average stimulation from three independent experiments.
Sanford et al.
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inserted either in a wild-type or in a mutant version that
lacked binding sites for SF2/ASF (pLCS-EDA or pLCS-
EDAmt, Fig. 3A). As a control, we generated a construct
containing a stop codon within the linker (pLCS-stop).
This is an ideal strategy to incorporate SR protein-bind-
ing sites into an ORF without perturbing the sequence or
structure of the reporter. After transfection into HeLa
cells, this reporter gene system is transcribed under the
control of the SV40 promoter, and translation initiating
at the unique ATG continues through the linker region
and leads to the synthesis of the luciferase reporter.
Thus, we were able to test the effect of an SR protein-
binding site with endogenous or transiently overex-
pressed SR proteins on translation of the reporter con-
struct by assaying luciferase levels. A Renilla luciferase
reporter driven by a thymidine kinase promoter was co-
Figure 3. SF2/ASF stimulates translation of a luciferase reporter mRNA in HeLa cells. (A) Schematic diagrams of the pLCS reporter
system. The fibronectin EDA ESE or a mutant version were inserted in frame and upstream of the Firefly luciferase ORF. After
cotransfection into HeLa cells with a Renilla luciferase reporter (driven by the thymidine kinase promoter), the pLCS reporters are
transcribed under the control of the SV40 promoter and translation leads to the synthesis of the reporter enzymes. The promega Dual
Luciferase Reaction (DLR) system is used to assay levels of the Firefly (translational reporter) and Renilla (to control for transfection
efficiency) luciferase levels. (B) The presence of an ESE stimulates expression of a Firefly Luciferase reporter mRNA. HeLa cells were
transiently transfected with pLCS-Stop, pLCS-EDA, or pLCS-EDAmt, which contains a mutation in the EDA sequence along with the
nonspecific Renilla luciferase reporter. The data are expressed as a ratio of Firefly luciferase activity to Renilla luciferase activity, and
have been normalized to changes in nuclear and cytoplasmic distribution of the reporter mRNAs. (C) Overexpression of SF2/ASF
stimulates expression of reporter mRNAs in vivo. HeLa cells were transiently transfected with pLCS-Stop, pLCS-EDA, or pLCS-EDAmt
along with the nonspecific Renilla luciferase reporter and pCGT7-SF2/ASF and analyzed as described above. (D) Analysis of the
nucleocytoplasmic distribution of reporter mRNAs (top) and of the cytosolic levels of reporter mRNA relative to the endogenous rpS8
mRNA (bottom) by RT–PCR. (E) Table summarizing the effects of the EDA ESE and overexpression of SF2/ASF on LCS reporter mRNA
distribution, cytoplasmic accumulation, and reporter enzyme expression.
SR proteins in translational regulation
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transfected as a control for transfection efficiency, and
data are expressed as a ratio between the enzymatic ac-
tivities of the two reporters. The luciferase activity val-
ues were corrected by the effects on mRNA export in-
duced by the presence of the ESE-binding site or overex-
pression of SF2/ASF (see below). We found that the
presence of the EDA exonic enhancer sequence, which is
recognized by SF2/ASF, stimulated luciferase activity by
nearly fourfold (Fig. 3B, cf. activity of pLCS EDA vs.
pLCS EDAmt). This effect most likely reflects the activ-
ity of endogenous SF2/ASF protein that is recruited by
the EDA enhancer, resulting in an increased translation
of the reporter mRNA. If this hypothesis were correct,
then we would predict that overexpression of SF2/ASF
should further stimulate luciferase activity. This is the
case, as transfected SF2/ASF strongly induces luciferase
activity of the reporter harboring the ESE sequence (Fig.
3C,E). An increase in the activity of the luciferase re-
porter lacking an ESE sequence was also observed upon
SF2/ASF overexpression, suggesting the presence of ad-
ditional binding sites (other than the inserted ESE se-
quence) for SF2/ASF within the luciferase ORF. Software
Figure 4. SF2/ASF stimulates the translation of both intronless and intron-containing reporter mRNAs. (A) Schematic diagrams of the
intronless and intron-containing LCS reporter mRNAs. The fibronectin EDA ESE or a mutant version were inserted in-frame and
upstream of the Firefly luciferase ORFs. (Right) Note the presence of an heterologous intron in the 5UTR. (B) The presence of an ESE
(EDA ESE) stimulates translation of both intronless and intron-containing Firefly Luciferase reporter mRNAs. HeLa cells were
transiently transfected with pLCS-Stop, pLCS-EDA, or pLCS-EDAmt, which contains a mutation in the EDA sequence along, lacking
or containing an intron, with the nonspecific Renilla luciferase reporter. The data are expressed as a ratio of Firefly luciferase activity
to Renilla luciferase activity. (C) Overexpression of SF2/ASF dramatically increases the expression of both intronless and intron-
containing LCS reporter mRNAs in HeLa cells. HeLa cells were transiently transfected with pLCS-Stop, pLCS-EDA, or pLCS-EDAmt
with or without an intron along with the nonspecific Renilla luciferase reporter and pCGT7-SF2/ASF and analyzed as described above.
Sanford et al.
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designed to predict the presence of SF2/ASF-binding sites
detects several additional potential binding sites within
the luciferase ORF, two of which show a strong resem-
blance to the EDA ESE (Cartegni et al. 2003). Interest-
ingly, under these conditions, the levels of the control
reporter, Renilla luciferase, which contains far fewer pu-
tative SF2/ASF-binding sites, remained unchanged (data
not shown). More importantly, the effect of the EDA ESE
sequence is maintained under SF2/ASF overexpression
(Fig. 3C,E).
We assayed nuclear and cytoplasmic reporter mRNA
levels to control that any increase in translation effi-
ciency may be due to an increase in mRNA export. RT–
PCR analysis was used to assay the amount of luciferase
mRNA reporter in nuclear and cytoplasmic total RNA
preps from cells cotransfected with SF2/ASF or a control
plasmid. The ratio of cytoplasmic to nuclear luciferase
mRNA remained relatively constant for both the LCS-
EDA and LCS-EDAmt (Fig. 3D, top, cf. lanes 1,2 and 3,4).
Although overexpression of SF2/ASF increased the pro-
portion of mRNAs in the cytoplasm, this effect was
similar for both LCS-EDA and LCS-EDAmt and did not
result in significant increases in the steady-state levels of
these RNAs in the cytoplasm when compared with an
endogenous mRNA (ribosomal protein rpS8; Fig. 3D,
bottom). Consequently, the results presented in Figure
3B and C have been normalized to reflect differences in
nuclear and cytoplasmic reporter mRNA levels. These
experiments demonstrate that overexpression of SF2/
ASF does not dramatically affect the extent of mRNA
export and/or stability, and further supports the hypoth-
esis that the primary effect of SF2/ASF in this assay is at
the level of translation (Fig. 3D,E).
The luciferase-based reporter mRNAs described above
lack introns, suggesting the possibility that SF2/ASF
may enhance the translation of intronless mRNAs. To
determine whether SF2/ASF could enhance the transla-
tion of spliced mRNAs, we generated a related series of
constructs that contain an intron in their 5UTR. Figure
4 clearly shows that SF2/ASF positively affects transla-
tion of both intron-containing and intronless reporter
mRNAs. The presence of an intron in these luciferase-
based reporters causes a general stimulation of gene ex-
pression; however, it does not substantially alter the
positive effect of translation mediated by an SF2/ASF-
binding site or by overexpressed SF2/ASF protein (Fig. 4).
Thus, the effect of SF2/ASF on translational regulation
does not require pre-mRNA splicing, raising the possi-
bility that it could affect translation of both intronless
and spliced mRNAs.
Nucleocytoplasmic shuttling of SR proteins is required
for their activity in translational activation
Our previous studies determined that the RS domain of
specific SR proteins determines the nucleocytoplasmic
properties of shuttling SR proteins (Caceres et al. 1998).
We have also previously shown that SC35 is actively
retained in the nucleus, due to the presence of a nuclear
retention sequence (NRS) in the C terminus of its RS
Figure 5. Nucleocytoplasmic shuttling of SF2/ASF is impor-
tant for stimulation of translation in vivo. (A) HeLa cells were
cotransfected with pLCS-EDA and empty vector (black bar),
pCGT7-SF2/ASF (gray bar), pCGT7-SF2/ASF-NRS (white bar),
or pCGT7-SC35 (hatched bar). Dual Luciferase assays measured
the effect of shuttling on the translation of the reporter en-
zymes. These data represent the average stimulation from three
independent experiments. (B) Analysis of the nucleocytoplas-
mic distribution of the reporter mRNAs (top) or of the cytosolic
levels of reporter mRNA relative to the endogenous rpS8
mRNA (bottom) by RT–PCR. (C) Table summarizing the effects
of overexpression of SF2/ASF, SF2/ASF-NRS, and SC35 on LCS
reporter mRNA distribution, cytoplasmic accumulation, and
reporter enzyme expression.
SR proteins in translational regulation
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domain, and that fusion of this NRS C-terminal of SF2/
ASF led to nuclear retention of this chimeric protein
(SF2/ASF–NRS; Cazalla et al. 2002). Thus, we asked if
the nucleocytoplasmic shuttling activity of SF2/ASF was
required to stimulate the expression of ESE containing
reporters in vivo. Whereas overexpression of wild-type
SF2/ASF activated translation of the luciferase reporter
harboring an SF2/ASF-binding site (pLCS-EDA), as
shown above, SC35 failed to activate translation of this
reporter (Fig. 5). Interestingly, the presence of a nuclear
retention signal in SF2/ASF dramatically reduces activa-
tion of the luciferase reporter (SF2/ASF–NRS; Fig. 5). As
in Figure 3, the luciferase activity was normalized to
reflect slight differences in the nuclear and cytoplamic
distribution of the luciferase reporter. Thus, compromis-
ing the shuttling ability of SR proteins causes a signifi-
cant reduction in the ability of SF2/ASF to activate trans-
lation in this assay.
Translational regulation by other shuttling SR proteins
in HeLa cells
The previous experiments suggest that SF2/ASF can
stimulate translation in vivo. To determine whether this
activity was common to other shuttling SR proteins, we
generated two additional LCS reporter constructs con-
taining binding sites for SRp20 and SC35 (Fig. 6A). The
motif chosen for SRp20 is an ESE from exon 4 of the
SRp20 gene, which is involved in the autoregulation of
SRp20 alternative splicing (Jumaa and Nielsen 1997),
whereas the SC35 motif was derived from a functional
SELEX approach (Liu et al. 2000). We found that the pres-
ence of the EDA exonic enhancer sequence, which is
recognized by SF2/ASF and 9G8, stimulated luciferase
activity by nearly fourfold as described above for Figure
3. In contrast, the presence of binding sites for either
SRp20 or SC35 does not enhance translation of the re-
spective reporter mRNAs (Fig. 6B). This experiment
most likely reflects the activity of the different endog-
enous SR proteins that are recruited by the different ESE
sequences. Thus, we conclude that endogenous SRp20
and SC35 fail to activate translation of reporters harbor-
ing their respective binding sites.
Next, we asked whether overexpression of different SR
proteins was able to activate translation of LCS reporter
mRNAs harboring binding sites for different SR proteins.
Western blot analysis demonstrated that each protein
Figure 6. Effect of shuttling SR proteins on the activation of translation of a luciferase reporter mRNA in HeLa cells. (A) Schematic
diagrams of the pLCS reporter constructs containing in-frame ESEs recognized by SF2/ASF and 9G8, SRp20 and SC35. (B) The presence
of the EDA ESE, but not the SRp20 ESE nor the SC35 ESE, stimulates expression of a Firefly Luciferase reporter mRNA. HeLa cells
were transiently transfected with pLCS-EDA, with pLCS-EDAmt, which contains a mutation in the EDA sequence, or with pLCS
SRp20 ESE and pLCS SC35 ESE along with the nonspecific Renilla luciferase reporter. The data are expressed as a ratio of Firefly
luciferase activity to Renilla luciferase activity. (C) Overexpression of SF2/ASF, but not of 9G8, SRp20, SC35, or hnRNP A1, stimulate
expression of the LCS EDA reporter mRNA in vivo. HeLa cells were cotransfected with pLCS-EDA and empty vector (control),
pCGT7-SF2/ASF, pCGT7-9G8, pCGT7-SRp20, pCGT7-SC35, and pCGT7-hnRNP A1 along with the nonspecific Renilla luciferase
reporter and pCGT7-SF2/ASF and analyzed as described above. (D) Table summarizing the effects of overexpression of SR proteins and
hnRNP A1 on LCS reporter mRNA distribution, cytoplasmic accumulation, and reporter enzyme expression.
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was overexpressed to comparable levels (data not
shown). As expected, SF2/ASF strongly activated the
EDA ESE-containing reporter (Fig. 6C). Interestingly,
overexpression of 9G8, which is known to regulate the
EDA ESE (Cramer et al. 1999) only marginally activated
expression of this reporter mRNA. Although 9G8 is not
a potent activator of the luciferase reporter harboring the
EDA ESE in this assay, we cannot rule out a positive role
for this shuttling SR protein in translation of mRNAs
harboring 9G8 high-affinitiy binding sites (Cavaloc et al.
1999). Furthermore, overexpression of SRp20 only
weakly activated expression of the reporter mRNA. As
described for Figures 3 and 5, the luciferase activity was
normalized for any effects of the overexpressed proteins
on mRNA nuclear/cytoplasmic distribution. In contrast
to SF2/ASF, overexpression of SC35 and the shuttling
RNA-binding protein hnRNP A1 failed to significantly
activate expression of the LCS EDA reporter. Moreover,
cotransfection of either SRp20 with the LCS SRp20 re-
porter construct or SC35 with the LCS SC35 reporter
construct failed to significantly increase the expression
of these reporter mRNAs (data not shown). Importantly,
overexpression of SR proteins does not dramatically af-
fect the extent of mRNA export and/or stability and fur-
ther supports the hypothesis that the primary effect of
SF2/ASF in this assay is at the level of translation (Fig. 6D)
SF2/ASF increases the utilization of reporter mRNA
by the translation machinery
The data presented above suggest that SF2/ASF plays a
role in translation. If this hypothesis is correct, then we
would predict that overexpression of SF2/ASF will in-
crease the utilization of the reporter mRNA by the trans-
lation machinery. We followed the association of the re-
porter mRNA with ribosomal complexes across sucrose
gradients in the presence or absence of SF2/ASF. A direct
role for SF2/ASF in the stimulation of translation should
result in a shift of the more efficiently translated reporter
mRNA being enriched in the polyribosome fractions of
sucrose gradients. This was indeed the case, as the dis-
tribution of the pLCS-EDA reporter shifted to the poly-
somes upon overexpression of SF2/ASF (Fig. 7). Taken
together, these data, along with those of the preceding
experiments, strongly suggest that the predominant ef-
fect of SF2/ASF on luciferase expression is at the level of
translation.
SF2/ASF enhances translation in a HeLa cell-free
translation system
Finally, a translationally competent HeLa cell-free ex-
tract was utilized to directly test whether SF2/ASF could
enhance translation in vitro (Bergamini et al. 2000). Re-
porter mRNAs analogous to those described in Figure 3
were synthesized in vitro and are shown schematically
in Figure 8A and D. We show that extracts programmed
with equal amounts of reporter mRNA constructs con-
taining an in-frame EDA ESE are translated more effi-
ciently than those carrying a mutated ESE. This demon-
strates that the presence of an heterologous SF2/ASF-
binding site within the ORF can dramatically enhance
translation (Fig. 8B). Moreover, reporter mRNAs con-
taining three copies of the EDA ESE were expressed
nearly three times greater than those containing a single
ESE, indicating that, as is the case in pre-mRNA splicing
(Graveley et al. 1998), ESE function additively rather
than synergistically in translation. These data suggest
that endogenous SF2/ASF present in the extract can
stimulate the translation of reporter mRNAs. Further-
more, addition of recombinant SF2/ASF protein en-
hances this translational activation (Fig. 8C). Interest-
ingly, heterologous EDA ESEs could also stimulate
translation of the luciferase reporter mRNA from the
3UTR, strongly suggesting that the effect of the ESE on
translation is independent of changing the coding capac-
ity of the reporter mRNA (Fig. 8D). Importantly, stimu-
lation of translation by SF2/ASF was observed in the ab-
sence of an increase in the stability of reporter mRNA, as
measured by Northern blots (data not shown). These
data indicate that SF2/ASF plays a direct role in transla-
tion in a cell-free system, programmed by equal amounts
of mRNA templates.
In summary, we have identified a novel cytoplasmic
function for shuttling SR proteins in translation. Al-
though the precise role of SR proteins in translation is
yet to be determined, our findings suggest that SR pro-
teins play numerous roles in the metabolism of mRNA
and posttranscriptional gene expression in both the
nuclear and cytoplasmic compartments of the cell.
Figure 7. Overexpression of SF2/ASF enhances translation of
reporter mRNAs. RT–PCR analysis of LCS EDA reporter
mRNA levels from HeLa cells transfected with pLCS EDA and
either empty expression vector (control) or pCGT7-SF2/ASF
(SF2/ASF) fractionated across a 10%–50% sucrose gradient as
described in Figure 1. Each transfection also contained the Re-
nilla luciferase reporter.
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Discussion
The nuclear roles of SR proteins in pre-mRNA splicing
have been extensively studied. In contrast, until only
recently, the cytosolic functions of shuttling SR proteins
have remained enigmatic. Cosedimentation of cytoplas-
mic SR proteins with the translation machinery sug-
gested that SR proteins might play a role in translational
regulation. This hypothesis was directly tested using
three different functional assays. First, we showed that
shuttling SR proteins could stimulate translation of re-
porter mRNAs when tethered via the MS2 protein in
Xenopus oocytes. This experimental approach provided
a direct assay of the ability of SF2/ASF to stimulate
translation independently of its RNA-binding speci-
ficity. Additionally, we developed a complementary
mammalian cellular system to assay the activity of
SR proteins in translation regulation, which not only
allowed us to independently confirm the results ob-
tained with the tethering system in Xenopus oocytes,
but also to test the requirement for nucleocytoplasmic
shuttling in translational activity. We found that the
presence of the fibronectin EDA ESE (a binding site for
SF2/ASF) can stimulate the expression of luciferase both
in vivo and in vitro. We also demonstrated that the abil-
ity of SR proteins to shuttle from the nucleus to the
cytoplasm plays a major role in their ability to stimulate
translation in vivo (Fig. 5). Thus, the regulation of the
nucleocytoplasmic shuttling activity may control
the levels of SF2/ASF in the cytoplasm and therefore
modulate translational regulation of mRNA targets of
SF2/ASF.
Figure 8. ESEs and recombinant SF2/ASF stimulate translation of reporter mRNAs in vitro. (A,B) Insertion of the EDA ESE into the
luciferase ORF stimulates translation in vitro. Constructs described in Figure 3A were transcribed in vitro. Reporter mRNAs (200 ng)
containing either one or three copies of a wild-type or mutant version of the EDA ESE were incubated in a HeLa translation extract.
Following incubation at 37°C, luciferase assays were performed (Promega). (C) Recombinant SF2/ASF stimulates expression of LCS
reporter mRNAs in vitro. In vitro translation reactions were performed in the presence (black bars) or absence (white bars) of
recombinant SF2/ASF (200 ng), as described above. (D) Insertion of the EDA ESE into the 3UTR enhances translation of the luciferase
reporter mRNA in vitro. Reporter mRNAs (100 ng) containing either six copies of a wild-type or mutant EDA ESE in the 3UTR were
incubated in HeLa translation extract. Following incubation at 37°C, luciferase assays were performed.
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It is possible that the role of SF2/ASF in translation
regulation may be associated with an early step in trans-
lation. We have clearly shown that overexpression of
SF2/ASF markedly induces a shift on the ESE-containing
reporter toward the polysomal fractions, strongly sug-
gesting that SF2/ASF is affecting translation initiation
(Fig. 7). Moreover, our finding that the EDA ESE can
stimulate the expression of a luciferase reporter mRNA
in vitro when present either in the ORF or the 3UTR,
strongly suggest that the effect of the ESE is at the level
of translation rather than the unlikely possibility that
the specific activity of the reporter enzyme encoded by
the LCS EDA and LCS EDAmt mRNAs differs dramati-
cally.
Recent work from several laboratories has demon-
strated functional coupling of different steps in the gene
expression pathway. It is widely thought that coordina-
tion of pre-mRNA synthesis with the RNA processing
machinery is important for regulating and optimizing
expression of eukaryotic genes and, that shuttling RNA-
binding proteins may play important roles in this pro-
cess. There is substantial evidence showing a clear effect
for an intron on gene expression. Two recent studies
showed that the presence of an intron not only influ-
ences 3 end processing, but also significantly enhances
the translational utilization of cytoplasmic mRNAs (Lu
and Cullen 2003; Nott et al. 2003). This stimulatory ef-
fect of introns on translation may, in part, be attributable
to the exon junction complex (EJC; Wiegand et al. 2003;
Nott et al. 2004).
Here, we have shown that splicing is not required for
the stimulatory role of shuttling SR proteins in transla-
tion, as SF2/ASF positively affects translation of both
intron-containing and intronless reporter mRNAs (Fig.
4). We have also shown that SF2/ASF is associated with
polyribosomes in cytoplasmic extracts and can enhance
translation both in vivo and in vitro. One plausible hy-
pothesis may be that shuttling SR proteins are involved
in regulating the translation of specific mRNA targets.
Elucidation of mRNA targets of shuttling SR proteins
will play a key role in understanding how shuttling SR
proteins influence cytoplasmic steps in gene expression.
Finally, our results underscore the impact of alterna-
tive pre-mRNA splicing in increasing the complexity of
the proteome. Most typically, alternative splicing deci-
sions lead to the generation of more than one mRNA
isoform. We have shown that the presence of an ESE in
an mRNA can stimulate its translation in vivo. These
data suggest the intriguing possibility that the ratio of
exon-included versus skipped mRNA isoforms would be
substantially amplified at the protein level by the en-
hanced translation of the ESE containing isoforms. Thus,
shuttling SR proteins may provide an unexpected level of
regulation and coupling between alternative pre-mRNA
splicing and mRNA translation.
In summary, we have shown that shuttling SR pro-
teins associate with the translational machinery and
stimulate translation in Xenopus oocytes and in mam-
malian cells in vivo, and also in a HeLa cell-free extract
system. Although the precise role of SR proteins in trans-
lation is yet to be determined, our findings suggest that
SR proteins play numerous roles in the metabolism
of mRNA in both the nuclear and cytoplamic com-
partments of the cell. Taken together, these results
strongly suggest that SR proteins are multifunctional
regulators of mRNA metabolism with diverse roles that
couple the processes of splicing, mRNA export, and
translation.
Materials and methods
Cell fractionation and sucrose gradient centrifugation
HeLa cells and HeLa Cell cytoplasmic extracts were purchased
from 4C Biotech. Cytoplasmic translation extracts were pre-
pared as described below. The salt concentration of the 4C bio-
tech cytoplasmic extract was adjusted to 20 mM Tris (pH 7.5),
5 mM MgCl2, 100 mM KCl, 0.3% NP-40. The extracts were
incubated for 10 min on ice, and insoluble material was pelleted
by centrifugation at 10,000 rpm for 10 min in a cold microfuge.
The resulting supernatant and/or HeLa cytoplasmic translation
extracts were then loaded onto a 10%–50% sucrose gradient
containing 20 mM Tris (pH 7.5), 5 mM MgCl2, 100 mM KCl and
centrifuged for 2 h at 38,000 rpm in a Sorval TH-641 rotor.
Following centrifugation, the gradients were fractionated using
a Pharmacia Superfrac fraction collector and the absorbance of
cytosolic RNA was at 254 nm and was recorded by an inline UV
monitor (Pharmacia). For transfection experiments, HeLa cells
were removed from a single T-75 flask with trypsin and washed
four times with 10 mL of ice-cold PBS. The cell pellet was then
resuspended in ice-cold lysis buffer (as described above) and in-
cubated on ice for 10 min. Nuclei and insoluble material were
then pelleted at 10,000 rpm for 10 min in a cold microfuge.
Sucrose gradient fractionation was carried out as described
above.
Antibodies
The following antibodies were used for Western blot analyses:
mAb anti-SF2/ASF (clone 96; Hanamura et al. 1998), mAb anti-
SRp20 (Neugebauer and Roth 1997), anti-PABP (Gorlach et al.
1994), anti-SRp40 (Snow et al. 1997), anti-rpS6 (Cell Signalling),
and anti-T7 monoclonal antibody (Novagen).
Western blot analysis
Protein samples isolated from sucrose gradient fractions, pel-
leted polysomes, or HeLa nuclear and cytosolic extracts were
resolved by SDS-PAGE. Proteins were then transferred to Hy-
bond P membranes (Amersham Pharmacia Biotech). Nonspe-
cific binding sites were blocked by incubation of the membrane
with 5% nonfat dry milk in TBST (20 mM Tris at pH 7.5, 137
mM NaCl, and 0.1% Tween 20). Proteins were detected using
the following primary antibodies (described above) diluted in
5% nonfat dry milk in TBST: mouse monoclonal anti-SF2/ASF
(1:500), mouse monoclonal anti-SRp20 (1:10), rabbit polyclonal
anti-PABP (1:2000), rabbit polyclonal anti-rpS6 (1:500), rabbit
polyclonal anti-SRp40 (1:1000), and mouse monoclonal anti-T7
(1:10,000). Following washing in TBST, blots were incubated
with the appropriate secondary antibodies conjugated to horse-
radish peroxidase (Pierce) and detected with Super Signal West
SR proteins in translational regulation
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Pico detection reagent (Pierce). For Figure 1, the membrane was
stripped (100 mM glycine at pH 2.5 and 50 mM NaCl), equili-
brated in TBST, blocked in 5% nonfat dry milk, and reprobed as
described above.
Microinjection of Xenopus oocytes
In vitro transcription, microinjection of Xenopus oocytes, and
luciferase assays were performed as previously described (Gray
et al. 2000).
Luciferase reporter system in HeLa cells
The parental plasmid used for the construction of the luciferase
reporter systems, pBPLUGA, was a generous gift of Dr. Ian Ep-
eron and has been described elsewhere (Kollmus et al. 1996).
pBPLUGA encodes a cassette containing -galactosidase, a
short linker sequence followed by the Firefly luciferase gene.
Oligonucleotides encoding an SF2/ASF ESE, or a mutated ver-
sion, were cloned into the BamHI and SalI sites between the
-galactosidase and luciferase genes, maintaining the ORF. Oli-
gonucleotides encoding an SRp20 or SC35 ESE were cloned into
the BamHI and SalI sites between the -galactosidase and lucif-
erase genes, maintaining the ORF. A total of 10 nM of comple-
mentary oligonucleotides were annealed in a 100-µL reaction
containing 1 M NaCl, 25 mM EDTA, 50 mM Tris (pH 7.5). The
solution was heated to 90°C for 5 min, then cooled to 50°C and
incubated for 1 h. The annealed oligos were then desalted by
two sequential G25 spin columns. The desalted annealed oligos
were then ligated directly into the pBPLUGA. The sequence of
each oligo is listed as follows: EDA forward, TCGAGAAGA
AGACG; EDA reverse, GATCCGTCTTCTTC; EDA mut for-
ward, TCGAGTTGTTGTCG; EDA mut reverse, GATCCGAC
AACAAC; SRp20 forward, TCGATCTCTTCTCG; SRp20 fe-
verse, GATCCGAGAAGAGA; SC35 forward, TCGAGGCCCC
TGCG; SC35 reverse, GATCCGCAGGGGCC; 3xEDA forward,
TCGAGAAGAAGACGAAGAAGACGAAGAAGAC; 3xEDA
reverse, GATCCGTCTTCTTCGTCTTCTTCGTCTTCTTC;
3xEDA mut forward, TCGAGTTGTTGTCGGTTGTTGTCG
GTTGTTGTCG; 3xEDA mut reverse, GATCCGACAACAAC
GACAACAACGACAACAAC.
The pLCS and pLuc plasmids (Figs. 3, 4, 8, respectively) were
generated by PCR amplification from the pBPLUGA plasmids
containing the ESE sequences. For pLCS, the 5 primer annealed
46 codons upstream from the luciferase ORF. For pLuc, the 5
primer annealed two codons upstream of the luciferase ATG.
Amplification with both primer sets yielded a full-length Firefly
luciferase ORF, preceded by either a 5 leader sequence derived
from the last 33 codons of -galactosidase, followed by the
SF2/ASF ESE (pLCS series) or by the 5 end of luciferase, lacking
any leader sequence (oligo sequences shown as follows): pLCS
5 (HindIII), GGGAAGCTTCAACAGATGGGGATTGGTG
GC; pLuc 5 (HindIII), GGGAAGCTTTTCCTCAGATGTCCC
GAGGATCC; pLuc 3(BamHI), GGGGGATCCTTACAATTT
GGACTTTCC.
The PCR products were digested with HindIII and EcoRV,
then cloned into pBPLUGA, and digested by HindIII and EcoRV,
resulting in the deletion of the -galactosidase sequence pres-
ent in the parental plasmid pBPLUGA. Intron-containing ver-
sions of the pLCS series were generated by amplifying the
chimeric intron from the TK-Renilla luciferase expression plas-
mid by PCR (Promega) using the following primers: 5 Intron
(XhoI), GGGCTCGAGGATTCTTCTGACACAACAG; 3 In-
tron (HindIII), GGGAAGCTTCTATAGTGAGTCGTATTAA.
The resulting PCR product was digested with XhoI and
HindIII and cloned directionally into the XhoI and HindIII sites
in the 5UTR of the pLCS plasmids.
The in vitro transcription constructs were generated by ex-
cising the complete pLCS or pLuc cassettes using HindIII and
KpnI and cloning into the same sites in pBlueScript (Stratagene).
pLuc 6xEDA and pLuc 6xEDAmt were constructed by cloning
oligos (sequence below) into the unique BglII site in the 3UTR
of pLuc. Transformants were screened by sequencing; due to the
nondirectional nature of this cloning strategy, multiple inser-
tion events were obtained. The 6xEDA and 6xEDAmt resulted
from ligation of two copies of the oligo dimers into either the
sense or antisense orientation: 3xEDA forward, GATCGAA
GAAGACGAAGAAGACGAAGAAGAC; 3xEDA reverse,
GATCGTCTTCTTCGTCTTCTTCGTCTTCTTC.
Cell transfection and dual luciferase assays
HeLa cells were grown to 90% confluence in 24-well plates. A
mixture of 1.6 µg of plasmid DNA consisting of 400 ng pLCS
reporter, 200 ng TK-Renilla Luciferase (Promega) and 1.0 µg of
the pCGT7 expression vector, and Lipofectamine 2000 (Invitro-
gen) was used to transfect cells following the manufacturers’
instructions. The transfection medium was replaced with fresh
medium after a 5-h incubation, and cells were then incubated
for another 42 h. For dual luciferase assays HeLa cells were lysed
using passive lysis buffer (Promega) and the levels of Firefly and
Renilla luciferase were assayed using Promega’s Dual Lucifer-
ase Assay Kit. The luminescence was measured with a Mono-
light 3010 luminometer (Pharmingen).
RNA isolation and RT–PCR
For mRNA analysis, HeLa cells were grown to 90% confluence
in 6-well plates and transfected with pLCS constructs, tk-Re-
nilla Luciferase and pCGT7 SF2/ASF or empty vector, as de-
scribed above. Cells were fractionated as described for the su-
crose gradient analyses, and total RNA was isolated from each
fraction using the TRI Reagent as described by the manufactur-
er’s instructions (Sigma). Following digestion with RQ DNAse
(Promega), the mRNAs for the pLCS reporter constructs and the
ribosomal protein rpS8 were amplified using the One Step RT–
PCR kit (Invitrogen) and the following primers: LCS forward,
CGGAATTCCAGCTGAGCG; LCS reverse, CAGGGCGTAT
CTCTTCATA; rpS8 forward, GGGTCTAGAATGGGCATCT
CTCGGGACA; rpS8 reverse, GGGGGATCCTTATTTGCCT
TTGCGGCC.
RT–PCR was carried out for 18, 22, 24, 28, 30, and 34 cycles
to determine the linear range of amplification. Densitom-
etry was performed using the software suite provided with the
QuantityOne imaging system (Bio-Rad). For RT–PCR analysis
of cytosolic reporter mRNA levels, equal amounts (1 µg) of total
RNA was reverse transcribed using oligo dT. The luciferase re-
porter mRNA and rpS8 mRNA were then amplified by PCR
using the primers described above. For RT–PCR analysis of lu-
ciferase reporters across sucrose gradients, one-third of each
fraction was extracted with TRI Reagent. Purified RNA was
digested with RQ DNAse, and cDNA was synthesised using the
LCS Reverse primer and Super Script Reverse Transcriptase (In-
vitrogen). One-quarter of the cDNA from each fraction was am-
plified by 40 cycles of PCR with LCS Forward and Reverse prim-
ers and Ampli-taq (Perkin Elmer). Northern blot analysis was
carried out are previously described (Gray et al. 2000).
Preparation of HeLa in vitro translation extracts and in vitro
translation reactions
HeLa Cell free extracts were prepared from 2.5 × 109 HeLa Cells
(4Cbiotech) as previously described (Bergamini et al. 2000).
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Translation reactions were programmed with 200 ng of reporter
mRNA in the presence or absence of 200 ng of recombinant
SF2/ASF (ProteinOne) or BC100 (20 mM Tris HCl at pH 7.5, 100
mM KCl, 0.2 mM EDTA, and 20% glycerol) and incubated at
37°C for 30 min. Reactions were stopped by dilution into 50 µL
passive lysis buffer (Promega). Luciferase activity was assayed
using Promega Luciferase Activating Reagent.
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